We discover, develop and commercialize biological products for agriculture.

As a research-driven company, we create biostimulant and biocontrol solutions that integrate seamlessly into conventional and organic crop protection and fertilizer markets.

Our solutions harness the power of biology to support healthier crops and more resilient farming systems. With versatility across the full spectrum of applications, from seed treatments to foliar sprays, we provide growers with flexible and effective options that complement their existing practices and help protect yields while improving soil health.

We’re not just creating products; we’re advancing the science of sustainable agriculture. By working with natural biological processes, our innovations enable farmers to optimize productivity while supporting long-term soil health, biodiversity and ecosystem vitality.

Today, Aphea.Bio brings together a diverse team of passionate scientists and technical experts from across industry and academia, united by a shared mission: to transform agriculture through biological solutions that benefit growers, consumers and the planet.

2017Founded in Ghent, Belgium

65People in the team

VIBSpin-off of VIB, Ghent University and KU Leuven

B CorpCertified B Corporation

Leadership team Our history Sustainability ↗︎Careers ↗︎

EXECUTIVE LEADERSHIP TEAM01 / MEET THE TEAM

Isabel Vercauteren

CHIEF EXECUTIVE OFFICER · CO-FOUNDER

Steven Vandenabeele

CHIEF SCIENTIFIC OFFICER · CO-FOUNDER

David Ingham

CHIEF DEVELOPMENT OFFICER

Rubik Sommerhalder

CHIEF COMMERCIAL OFFICER

Gerald Coward

CHIEF FINANCIAL OFFICER

Board of directors ↗︎Join the team ↗︎

OUR HISTORY02 / 2017 TO TODAY

From spin-off to scale-up.

202565 EMPLOYEESSubmission of the first biocontrol regulatory dossier for VIRTUOSA^® in the US and EU · Silver medal awarded in first EcoVadis assessment

202355 EMPLOYEESRegistration and launch of first biostimulant, ACTIV by Aphea.Bio™ · B Corp certification · inauguration of pilot-scale production facility · closed Series C funding round with €70 million

202243 EMPLOYEESSubmission of first biostimulant dossier for market authorization · first commercial agreement signed

202136 EMPLOYEESFull product development team established, ranging from mode of action, field trials, production & formulation to regulatory affairs · nomination of first commercial product candidates, proof of concept under field conditions

202030 EMPLOYEESField-validated leads ready for product development track · established pipelines for bioinsecticides and bioherbicides · closed Series B funding round with €19.8 million

201921 EMPLOYEESExceeded 10k unique strains in the proprietary collection · first biofungicide field trials run · facility expansion at Bioaccelerator

201817 EMPLOYEESBiostimulant and biocontrol programs established with discovery pipelines (screening platforms) for wheat, climate chambers and automated phenotyping in greenhouse · first initial field trials for biostimulants · first IP filings submitted

201710 EMPLOYEESFounded as VIB spin-off in July 2017 · established greenhouse and lab facilities at Bioaccelerator in the Technologiepark Gent · closed Series A funding with €7.7 million

LIFE AT APHEA.BIOOUR TEAM

Meet our team.

Photo note: a collage of several team photos (lab, greenhouse, field trials, team moments). @Aphea.Bio team: please share whatever you have.

Sustainability ↗︎

A core pillar of our philosophy. Certified B Corporation.

Technology ↗︎

APEXbio™, our path from discovery to market.

Careers ↗︎

Challenge the conventional. Change the norm with us.